In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
MedImmune Reacquires Rights To Intranasal Influenza Vaccine From Wyeth
FTC Clears MedImmune Reacquisition of Intranasal Influenza Vaccine Products
U.S. FDA Licenses Sanofi Pasteur’s New Influenza Vaccine Manufacturing Facility
Neugenesis and PATH sign collaboration agreement to develop an influenza vaccine production system
MedImmune Incorporates Reacquisition of FluMist(TM) Franchise from Wyeth into Financial Guidance
Medimmune licenses Biowa, Inc.'s Potelligent™ Technology for use in antibody development
MedImmune Amends Agreement for Cervical Cancer Vaccine With Glaxosmithkline
MedImmune licenses cancer target
Medicago and Genopole® sign agreement for influenza vaccine production in France
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
